RAP, a specialized chaperone, prevents ligand-induced ER retention and degradation of LDL receptor-related endocytic receptors

Thomas E. Willnow, Astrid Rohlmann, Jay Norton, Hideo Otani, Jürgen R. Braun, Robert E Hammer, Joachim Herz

Research output: Contribution to journalArticle

226 Citations (Scopus)

Abstract

The multifunctional low density lipoprotein (LDL) receptor-related protein (LRP) forms a complex with a receptor-associated protein (RAP) within the secretory pathway. RAP inhibits ligand binding to LRP and is required for normal functional expression of LRP in vivo, suggesting a physiological function as a specialized chaperone. We have used RAP-deficient mice, generated by gene targeting, to investigate the role of RAP in the biosynthesis and biological activity of LRP and other members of the LDL receptor gene family in various organs and in embryonic fibroblasts. Our results demonstrate that RAP is required for the proper folding and export of the receptors from the endoplasmic reticulum (ER) by preventing the premature binding of co-expressed ligands. Overexpression of apolipoprotein E (apoE), a high affinity ligand for LRP, results in dramatically reduced cellular LRP expression, an effect that is prevented by co-expression of RAP. RAP thus defines a novel class of molecular chaperones that selectively protect endocytic receptors by binding to newly synthesized receptor polypeptides, thereby preventing ligand-induced aggregation and subsequent degradation in the ER.

Original languageEnglish (US)
Pages (from-to)2632-2639
Number of pages8
JournalEMBO Journal
Volume15
Issue number11
StatePublished - 1996

Fingerprint

Low Density Lipoprotein Receptor-Related Protein-1
LDL Receptors
Endoplasmic Reticulum
Ligands
Degradation
Proteins
LDL-Receptor Related Proteins
Molecular Chaperones
Gene Targeting
Genes
Secretory Pathway
Protein Biosynthesis
Apolipoproteins E
Biosynthesis
Fibroblasts
Bioactivity
Peptides
Agglomeration

Keywords

  • Alzheimer's disease
  • ApoE
  • Secretory pathway

ASJC Scopus subject areas

  • Genetics
  • Cell Biology

Cite this

RAP, a specialized chaperone, prevents ligand-induced ER retention and degradation of LDL receptor-related endocytic receptors. / Willnow, Thomas E.; Rohlmann, Astrid; Norton, Jay; Otani, Hideo; Braun, Jürgen R.; Hammer, Robert E; Herz, Joachim.

In: EMBO Journal, Vol. 15, No. 11, 1996, p. 2632-2639.

Research output: Contribution to journalArticle

Willnow, Thomas E. ; Rohlmann, Astrid ; Norton, Jay ; Otani, Hideo ; Braun, Jürgen R. ; Hammer, Robert E ; Herz, Joachim. / RAP, a specialized chaperone, prevents ligand-induced ER retention and degradation of LDL receptor-related endocytic receptors. In: EMBO Journal. 1996 ; Vol. 15, No. 11. pp. 2632-2639.
@article{f4327f6938704881a27cf34a766a1e09,
title = "RAP, a specialized chaperone, prevents ligand-induced ER retention and degradation of LDL receptor-related endocytic receptors",
abstract = "The multifunctional low density lipoprotein (LDL) receptor-related protein (LRP) forms a complex with a receptor-associated protein (RAP) within the secretory pathway. RAP inhibits ligand binding to LRP and is required for normal functional expression of LRP in vivo, suggesting a physiological function as a specialized chaperone. We have used RAP-deficient mice, generated by gene targeting, to investigate the role of RAP in the biosynthesis and biological activity of LRP and other members of the LDL receptor gene family in various organs and in embryonic fibroblasts. Our results demonstrate that RAP is required for the proper folding and export of the receptors from the endoplasmic reticulum (ER) by preventing the premature binding of co-expressed ligands. Overexpression of apolipoprotein E (apoE), a high affinity ligand for LRP, results in dramatically reduced cellular LRP expression, an effect that is prevented by co-expression of RAP. RAP thus defines a novel class of molecular chaperones that selectively protect endocytic receptors by binding to newly synthesized receptor polypeptides, thereby preventing ligand-induced aggregation and subsequent degradation in the ER.",
keywords = "Alzheimer's disease, ApoE, Secretory pathway",
author = "Willnow, {Thomas E.} and Astrid Rohlmann and Jay Norton and Hideo Otani and Braun, {J{\"u}rgen R.} and Hammer, {Robert E} and Joachim Herz",
year = "1996",
language = "English (US)",
volume = "15",
pages = "2632--2639",
journal = "EMBO Journal",
issn = "0261-4189",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - RAP, a specialized chaperone, prevents ligand-induced ER retention and degradation of LDL receptor-related endocytic receptors

AU - Willnow, Thomas E.

AU - Rohlmann, Astrid

AU - Norton, Jay

AU - Otani, Hideo

AU - Braun, Jürgen R.

AU - Hammer, Robert E

AU - Herz, Joachim

PY - 1996

Y1 - 1996

N2 - The multifunctional low density lipoprotein (LDL) receptor-related protein (LRP) forms a complex with a receptor-associated protein (RAP) within the secretory pathway. RAP inhibits ligand binding to LRP and is required for normal functional expression of LRP in vivo, suggesting a physiological function as a specialized chaperone. We have used RAP-deficient mice, generated by gene targeting, to investigate the role of RAP in the biosynthesis and biological activity of LRP and other members of the LDL receptor gene family in various organs and in embryonic fibroblasts. Our results demonstrate that RAP is required for the proper folding and export of the receptors from the endoplasmic reticulum (ER) by preventing the premature binding of co-expressed ligands. Overexpression of apolipoprotein E (apoE), a high affinity ligand for LRP, results in dramatically reduced cellular LRP expression, an effect that is prevented by co-expression of RAP. RAP thus defines a novel class of molecular chaperones that selectively protect endocytic receptors by binding to newly synthesized receptor polypeptides, thereby preventing ligand-induced aggregation and subsequent degradation in the ER.

AB - The multifunctional low density lipoprotein (LDL) receptor-related protein (LRP) forms a complex with a receptor-associated protein (RAP) within the secretory pathway. RAP inhibits ligand binding to LRP and is required for normal functional expression of LRP in vivo, suggesting a physiological function as a specialized chaperone. We have used RAP-deficient mice, generated by gene targeting, to investigate the role of RAP in the biosynthesis and biological activity of LRP and other members of the LDL receptor gene family in various organs and in embryonic fibroblasts. Our results demonstrate that RAP is required for the proper folding and export of the receptors from the endoplasmic reticulum (ER) by preventing the premature binding of co-expressed ligands. Overexpression of apolipoprotein E (apoE), a high affinity ligand for LRP, results in dramatically reduced cellular LRP expression, an effect that is prevented by co-expression of RAP. RAP thus defines a novel class of molecular chaperones that selectively protect endocytic receptors by binding to newly synthesized receptor polypeptides, thereby preventing ligand-induced aggregation and subsequent degradation in the ER.

KW - Alzheimer's disease

KW - ApoE

KW - Secretory pathway

UR - http://www.scopus.com/inward/record.url?scp=0029887302&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029887302&partnerID=8YFLogxK

M3 - Article

VL - 15

SP - 2632

EP - 2639

JO - EMBO Journal

JF - EMBO Journal

SN - 0261-4189

IS - 11

ER -